国产人人色I色婷婷综合久久中文字幕雪峰I奇米色777欧美一区二区I久热久热aV爽青青在线I国产av喷水I国产伦精品一区二区三区免.费I高潮av在线Iww欧美一级I91天天看I黄a在线91I九一无码中文字幕久久无码色…I丰满国产精品视频二区

Growth of pet cloning means love never dies

By Yang Wanli | China Daily | Updated: 2019-06-18 10:01
Share
Share - WeChat
A veterinarian conducts surgery on a surrogate mother dog at a lab owned by Sinogene, the first biotech company in China to provide pet-cloning services, in Beijing last month. Wang Zhuangfei / China Daily

'Rebirth'

Dogs' barks could clearly be heard in the corridors outside Sinogene's lab at a science and technology park in a northern suburb of Beijing earlier this month.

On the monitors, three plump cloned puppies could be seen sleeping next to their surrogate mothers. In about two months, they will see their owners.

The lab is where the miracle of Guai Guai's "rebirth" will happen. Once the cloning procedure starts, a veterinarian will harvest eggs from a healthy female dog and Guai Guai's DNA will be inserted into them, fusing with the cells to produce embryos genetically identical to the dead pet.

Unlike the assisted reproductive technique for humans in which two to four embryos are usually implanted, only one or two dog embryos out of every 15 created can be successfully grown and then born.

The process usually lasts six to 10 months. The client only takes possession of their cloned pet when it is about 2 months old, an age at which it is less likely to die as a result of rejecting artificial nutrients after being removed from its breastfeeding surrogate mother.

The clone is tested by an independent company, which provides a certificate confirming its genetic connection with the original pet.

Since Sinogene started cloning pets, it has produced about 30 dogs, ranging from Chihuahuas to Tibetan mastiffs, and if all goes well, the lab will see its first cloned cat by the end of the month.

"The scientific community has always considered dog cloning to be the most difficult procedure, because poor egg quality and the asynchronous (unsynchronized) reproduction cycle of the surrogate mother both pose great challenges to the cloning process," said Zhao Jianping, Sinogene's vice-president.

|<< Previous 1 2 3 4 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US